(PDF) Results of the First Double Blind Placebo (Pl)

Results of the First Double Blind Placebo (Pl) Controlled Study of Caffeine Citrate (Cc) for the Treatment of Apnea of Prematurity (Aop) † 1001

Pediatric Research - United States

doi 10.1203/00006450-199804001-01022

Full Text

Abstract

Available in full text

Categories

Date

April 1, 1998

Authors

Publisher

Springer Science and Business Media LLC

Related search

Sarilumab for the Treatment of Ankylosing Spondylitis: Results of a Phase II, Randomised, Double-Blind, Placebo-Controlled Study (ALIGN)

Annals of the Rheumatic Diseases

Molecular Biology

English

Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study

Journal of Affective Disorders

Clinical Psychology

English

Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Frontiers in Pediatrics

English

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial

Arthritis and Rheumatology

English

Safety of Sildenafil Citrate: Review of 67 Double-Blind Placebo-Controlled Trials and the Postmarketing Safety Database

International Journal of Clinical Practice

English

Aripiprazole for the Treatment of Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

English

A Double-Blind, Placebo-Controlled Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence

Addictive Behaviors

Clinical Psychology

English

Double-Blind, Placebo Controlled, Crossover Study of Lamotrigine in Treatment Resistant Partial Seizures.

Journal of Neurology, Neurosurgery and Psychiatry

English

Escitalopram and Paroxetine in the Treatment of Generalised Anxiety Disorder: Randomised, Placebo-Controlled, Double-Blind Study

British Journal of Psychiatry

English